Graham, C., Kao, R., Cao, Q., McDonald-Hyman, C., Norton, J., Grover, P., Maakaron, J., Allred, J., Bachanova, V., Miller, J., Weisdorf, D., Juckett, M. (2025). Risk of relapse and mortality after non-myeloablative allogeneic stem cell transplant for Acute Myeloid Leukemia and myelodysplastic syndrome after fludarabine, cyclophosphamide, and 200 centigray total body irradiation  with gvhd prophylaxis using post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil: Impact of maintenance chemotherapy. Blood. https://doi.org/10.1182/blood-2025-7781